$$$Ospreyeye: Charts, Technical Analysis & Japanese Candlestick Patterns$$$

[BottomBounce]

$AMRS Reaction from the Street

Jeffrey Osborne at Cowen & Company wrote:

Amyris reported revenues of $9.6 mn, coming in below both Cowen and Street estimates of $10.6 mn and $15.22 mn respectively due to timing of product shipments and collaboration payments. About 90% of its revenue for 2016 and about 70% of its revenue for 2017 [is] committed.

Finally, the company expects continued growth from personal care as well as a significant ramp up in health and industrial segments in the second half, with ~33% coming from health, ~40% coming from personal care, and the rest coming from industrials. We are taking a wait and see approach given the uncertain pace of cost reductions. $1.25 price target.